Double Stent for Biliary Stones in Cirrhotic Patients
Double Versus Single Plastic Stents for Non-Retrievable Biliary Stones in Cirrhotic Patients
2 other identifiers
interventional
400
1 country
1
Brief Summary
This prospective, single-center, interventional study enrolled 400 cirrhotic patients with large or complex common bile duct (CBD) stones that could not be removed during an initial Endoscopic Retrograde Cholangiopancreatography (ERCP). The study compared four different plastic biliary stenting strategies (single 10 Fr, double 10 Fr, single 11.5 Fr, and single 10 Fr pigtail stents) to determine the optimal approach for facilitating successful stone clearance in a subsequent ERCP and minimizing complications in this high-risk patient population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2025
CompletedFirst Submitted
Initial submission to the registry
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedFirst Posted
Study publicly available on registry
January 13, 2026
CompletedJanuary 13, 2026
December 1, 2025
3 years
January 1, 2026
January 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Stent Patency
Time from stent placement until clinical or biochemical evidence of stent occlusion (e.g., cholangitis, elevated liver enzymes, or imaging findings).
6 months
Successful Stone Clearance in Second ERCP
The proportion of patients in each group achieving complete clearance of common bile duct stones during the second, planned ERCP session.
6 months
Secondary Outcomes (3)
Incidence of Procedure-Related Complications
From stenting until 30 days after the second ERCP.
Reduction in Stone Size
6 months
All-Cause Mortality
12 months
Study Arms (4)
Single 10 Fr Plastic Stent
EXPERIMENTALPlacement of a single 10 French (Fr), 10 cm plastic biliary stent.
Double 10 Fr Plastic Stents
EXPERIMENTALPlacement of two 10 French (Fr), 10 cm plastic biliary stents side-by-side.
Single 11.5 Fr Plastic Stent
EXPERIMENTALPlacement of a single 11.5 French (Fr), 10 cm plastic biliary stent.
Single 10 Fr Pigtail Stent
EXPERIMENTALPlacement of a single 10 French (Fr), 10 cm pigtail plastic biliary stent.
Interventions
Single 10 Fr, 10 cm plastic stent placed endoscopically.
Two 10 Fr, 10 cm plastic stents placed endoscopically.
Single 11.5 Fr, 10 cm plastic stent placed endoscopically.
Single 10 Fr, 10 cm pigtail plastic stent placed endoscopically.
Eligibility Criteria
You may qualify if:
- Adults with established liver cirrhosis.
- Presence of large or complex common bile duct (CBD) stones that were non-retrievable during the initial ERCP.
- Classified as high-risk due to moderate to severe liver disease and/or substantial comorbidities, making them unable to safely tolerate extended endoscopic procedures or surgical intervention.
- Clinically stable and capable of undergoing the scheduled diagnostic and therapeutic procedures.
- Provided signed informed consent before enrollment.
You may not qualify if:
- Non-cirrhotic patients.
- Patients with non-calculous causes of biliary obstruction (e.g., portal biliopathy, benign biliary strictures, or malignant biliary obstruction).
- Acute suppurative cholangitis.
- Contraindications to ERCP.
- Inability to complete the scheduled 12-month follow-up time.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Liver Institute, Menoufia University, Egypt.
Shibīn al Kawm, Menoufia, 32511, Egypt
Related Publications (3)
Lee TH, Han JH, Kim HJ, Park SM, Park SH, Kim SJ. Is the addition of choleretic agents in multiple double-pigtail biliary stents effective for difficult common bile duct stones in elderly patients? A prospective, multicenter study. Gastrointest Endosc. 2011 Jul;74(1):96-102. doi: 10.1016/j.gie.2011.03.005. Epub 2011 Apr 30.
PMID: 21531412BACKGROUNDHoriuchi A, Nakayama Y, Kajiyama M, Kato N, Kamijima T, Graham DY, Tanaka N. Biliary stenting in the management of large or multiple common bile duct stones. Gastrointest Endosc. 2010 Jun;71(7):1200-1203.e2. doi: 10.1016/j.gie.2009.12.055. Epub 2010 Apr 18.
PMID: 20400079BACKGROUNDBinmoeller KF, Schafer TW. Endoscopic management of bile duct stones. J Clin Gastroenterol. 2001 Feb;32(2):106-18. doi: 10.1097/00004836-200102000-00004.
PMID: 11205644BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 1, 2026
First Posted
January 13, 2026
Study Start
January 1, 2022
Primary Completion
January 1, 2025
Study Completion
January 1, 2026
Last Updated
January 13, 2026
Record last verified: 2025-12